🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

At #ASCO25, the Joint Session between ASCO and ESMO - Eur. Oncology will discuss emerging trends & the implications of integrating biomarker testing into clinical care. #ASCODailyNews has more on this with: Robin Zon, MD, FACP, FASCO Ben Westphalen FabriceAndre Arturo LoAIza-Bonilla, MD MSEd Julie Gralow: brnw.ch/21wSLDe

ASCO is leading the way in AI and oncology, and something new is on the horizon for ASCO members. #ASCO25. Stay tuned.

Investing in #CancerResearch saves lives! Urge your lawmakers to support FY26 funding for NIH, National Cancer Institute, & ARPA-H. #ASCOAdvocacy Act now: brnw.ch/21wSNsh

Recommend a colleague by June 6, 2025, for the upcoming ASCO Election. Learn more and submit your recommendations: brnw.ch/21wSNAe

Prepping for #ASCO25? Preview education sessions with the #ASCOEdBook. New articles publish daily, authored by meeting faculty. Visit: brnw.ch/21wSOQ8

🚨New from ASCO: The ASCO Guidelines Assistant, a new generative AI tool developed in collaboration with @GoogleCloud, more quickly connects ASCO members with timely and trustworthy information. #ASCO25 Learn more: brnw.ch/21wSPeh

Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in STAT brnw.ch/21wSPi7

Our members report care delays that impact outcomes and an increase in time spent on paperwork rather than pt care bc of prior auth processes. Urge your lawmakers to pass this bill to help #FixPriorAuth: brnw.ch/21wSPlF #ASCOAdvocacy

Know some great people in the #ASCO25 online community? Time to meet them in person! Join us for the Social Media Meetup on Friday, May 30th, from 5:00 to 6:00 PM at McCormick Place – 2.5 Lounge. Come connect, chat, and build those relationships offline.

Time is up ⌛️ #ASCO25 abstracts are releasing today at 5 pm ET! 2 tips before the meeting: 1- Do not forget to update your ASCO app📲 in your mobile phone!📱 2- Check the meeting program and create your own via either phone or PC🧑‍💻! ...and enjoy during #ASCO25 with the

I am honored to be a #ASCO25 Featured Voice! I will amplify trainee posts and research on #DrugDevelopment, #SurvOnc and global oncology. 📢 Hosting the BlueSky Takeover for ASCO about “AI and Cancer Care” on June 1 at 4:30 PM #Oncology #GlobOnc #ClinicaPharmacology #oncologia

The ASCO Guidelines Assistant is built for how oncologists work today. Powered by AI and developed in partnership with @GoogleCloud, it delivers fast, evidence-based answers drawn exclusively from ASCO’s clinical practice guidelines. Explore More: brnw.ch/21wSQFR

AI is already making an impact in cancer research and care, but in which direction is the field heading? At #ASCO25, 3 Education Sessions will tackle the latest advancements, challenges, and future directions of AI in oncology. ASCO Daily News has more: brnw.ch/21wSQVS

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: brnw.ch/21wSR0A ASCO

An understanding of the pathogenesis of treatment-related complications can inform therapeutic strategies for childhood cancer survivors. #ASCOEdBook Read more: brnw.ch/21wSR3j

The most clinically relevant science in oncology will be presented at #ASCO25, and you can now view the full 5,000 abstracts & their presentation date, time & location info: brnw.ch/21wSRrE

🎙 Dr. John Sweetenham and Erika Hamilton, MD of Sarah Cannon Docs analyze several just-released abstracts that will be presented at this year's Annual Meeting on this special #ASCO25 preview episode of the #ASCODailyNews Podcast: brnw.ch/21wSRth

🚨🗞️ News from #ASCO25 via Carla K. Johnson & The Associated Press Latest buzz on GLP-1 drugs: may lower cancer risk in people with diabetes. brnw.ch/21wSRuT

📍Now it's time to highlight those abstracts that we'll see at #ASCO25 in kidney & bladder confirming their value as standard of care: 🏹1. #CHECKMATE-214: Among those patients who responded to Nivo-Ipi (42%) with 1L I/P prognosis, the possibilities to maintain the response

Congrats to the 2025-2026 ASCO Leadership Development Program (LDP) & LDP: Education Scholars! 🎉These members will hone leadership skills while learning about program-specific strategies and goals. Want to join next year? Applications open this summer! ➡️ brnw.ch/21wSSsa